Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 25,052Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240627580631/en

BUSINESSWIRE
27 Jun 2024

https://www.globenewswire.com/news-release/2022/10/10/2531336/30446/en/Aravive-Receives-Third-Development-Milestone-from-3D-Medicines.html

GLOBENEWSWIRE
10 Oct 2022

https://www.globenewswire.com/news-release/2022/09/20/2519421/0/en/Junshi-Biosciences-Receives-NMPA-Approval-of-sNDA-for-Toripalimab-in-Combination-with-Chemotherapy-as-First-Line-Treatment-for-Advanced-Non-squamous-Non-Small-Cell-Lung-Cancer.html

GLOBENEWSWIRE
20 Sep 2022

https://www.pharmacompass.com/pdf/news/motto-international-corp-issues-voluntary-recall-of-bull-platinum-1576839037.pdf

FDA
19 Dec 2019

https://www.biospace.com/article/releases/merck-receives-positive-eu-chmp-opinion-for-two-new-regimens-of-keytruda-pembrolizumab-as-first-line-treatment-for-metastatic-or-unresectable-recurrent-head-and-neck-squamous-cell-carcinoma-/?s=95

BIOSPACE
19 Oct 2019

https://www.fiercepharma.com/marketing/astrazeneca-s-imfinzi-hits-survival-goal-tees-up-small-cell-lung-cancer-i-o-fight-roche

Angus Liu FIERCE PHARMA
28 Jun 2019